(Q37073656)

18 August 2017

1 reference

title

Neurocognitive disturbances in HIV. (English)

1 reference

18 August 2017

0 references

Igor Grant

1

1 reference

18 August 2017

publication date

1 February 2008

1 reference

International Review of Psychiatry

18 August 2017

published in

1 reference

18 August 2017

volume

20

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

33-47

1 reference

Neuropsychologic impairment in early HIV infection. A risk factor for work disability.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Updated research nosology for HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Qualitative features of the memory deficit associated with hiv infection and AIDS: Cross-validation of a discriminant function classification scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Cognitive development in school-age children with vertically transmitted HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Initial validation of a screening battery for the detection of HIV-associated cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Organic impairment in polydrug users: risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Evaluating the neurocognitive complications of SLE. Lessons from HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

The effect of previous alcohol abuse on cognitive function in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

The correlation between neuropsychological and neuroanatomic changes over time in asymptomatic and symptomatic HIV-1-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Reaction time performance in adults with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Risky decision making assessed with the gambling task in adults with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

A comparison of clinical and automated interpretation of the Halstead-Reitan Battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Dual task performance in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Verbal fluency in HIV infection: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Reading level attenuates differences in neuropsychological test performance between African American and White elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Abnormalities of visual spatial attention in HIV infection and the HIV- associated dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Noopsychological changes and psychopathological characteristics of HIV-1 patients of various risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

A meta-analysis of the neuropsychological sequelae of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Retrograde amnesia in dementia: comparison of HIV-associated dementia, Alzheimer's disease, and Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Recency effects in HIV-associated dementia are characterized by deficient encoding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

HIV infection and cognition in intravenous drug users: long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Neuropsychological changes in a prospectively followed cohort of homosexual and bisexual men with and without HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

The California Verbal Learning Test--second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

Action (verb) fluency predicts dependence in instrumental activities of daily living in persons infected with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701877894

10.1080/09540260701877894

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference